Fibrocytes were cultured for 8 days whereas skin fibroblasts were cultured up to 80% confluency prior to treatment with CTLA4-Ig, as described in the “Cell culture and treatments” section above.
Total RNA was extracted with
NucleoSpin RNA/protein (Macherey-Nagel) and quantified by
NanoDrop (Thermo Scientific), which also evaluates RNA integrity, in accordance with the manufacturer’s instructions. For each experimental condition, first-strand cDNA was synthesized from 1 μg total RNA using the
QuantiTect Reverse Transcription Kit (Qiagen).
qRT-PCR was performed on an Eppendorf
Realplex 4 Mastercycler using the
Real MasterMix SYBR Green detection system (Eppendorf) in a total volume of 10 μl loaded in triplicate. Primers for CD86 (NM_175862.4), COL I (NM_000088), FN (NM_002026), TGFβ (NM_000660), αSMA (NM_001613), S100A4 (NM_002961), CXCR2 (NM_00116829), CXCR4 (NM_00100854), CD11a (NM_00111438), and β-actin (NM_001101, housekeeping gene) were supplied by Primerdesign.
Gene expression values were calculated using the comparative ΔΔCT method and they corresponded to the expression level (fold-increase) of the target gene compared with the calibrator sample (untreated cells) taken as the unit value by definition [32 (
link)]. In each qRT-PCR assay, the melting curve was performed to confirm the specificity of the SYBR green assay.
Cutolo M., Soldano S., Montagna P., Trombetta A.C., Contini P., Ruaro B., Sulli A., Scabini S., Stratta E., Paolino S., Pizzorni C., Smith V, & Brizzolara R. (2018). Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay. Arthritis Research & Therapy, 20, 157.